Identification | |
Name | Dronedarone Hydrochloride |
Other names |
141625-93-6 Dronedarone HCl N-(2-Butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)benzofuran-5-yl)methanesulfonamide hydrochloride
Dronedarone, HCl
|
CAS number | 141625-93-6 |
Molecular Formula | C 31 H 45 ClN 2 O 5 S |
Molecular Weight | 593.224 |
EINECS | 630-355-2 |
Chemical and Physical Properties | |
Appearance | White to off-white powder |
Melting point | 220°C |
Quality standard | CP/USP |
Application | |
Drug Indication/Application/Use | Dronedarone Hydrochloride is an antiarrhythmic drug. It is applicable to patients with paroxysmal or persistent atrial fibrillation (AF) or atrial flutter (AFL) to reduce the risk of hospitalization, recent AF/AFL attacks and patients with cardiovascular risk factors, and patients with sinus rhythm or reversible rhythm. |
Formulations/Preparations |
Tablet
Powder for Suspension Tablet, Chewable Tablet, Extended Release Capsule |
Handling and Storage | |
Safety and Hazards | The Shanghai Research Institute of Chemical industry testing center identification conclusion :1 No hazard identification, 2 The substance is not subject to IATA DGR, 3 Nonpacking requirements. |
Handling and Storage | Store at a controlled room temperature 20 -25°C (68 -77°F) |
Sample package | Double plastic bags inside, aluminum foil bag outside |
Commercial package | Double plastic bags inside,5kg, 10kg, and 25kg fiber drum outside. |
UN Code | Not classified |
HS Code | 2935904000 |
Shipping group | Shipment at ambient temperature for no controlled and no dangerous goods |
Sales restriction | No |
Origin | China |